Tersera Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TERSERA, and what generic alternatives to TERSERA drugs are available?
TERSERA has eight approved drugs.
There are seventeen US patents protecting TERSERA drugs.
There are two hundred and twenty-one patent family members on TERSERA drugs in thirty-eight countries and forty-one supplementary protection certificates in eighteen countries.
Summary for Tersera
| International Patents: | 221 |
| US Patents: | 17 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 8 |
Drugs and US Patents for Tersera
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | RX | Yes | Yes | 9,707,270 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-003 | Dec 28, 2004 | DISCN | No | No | 9,707,270 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-003 | Dec 28, 2004 | DISCN | No | No | 8,765,680 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | VARUBI | rolapitant hydrochloride | EMULSION;INTRAVENOUS | 208399-001 | Oct 25, 2017 | DISCN | Yes | No | 8,404,702 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | ERGOMAR | ergotamine tartrate | TABLET;SUBLINGUAL | 087693-001 | Feb 24, 1983 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | RX | Yes | Yes | 8,653,033 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-004 | Dec 28, 2004 | RX | Yes | Yes | 9,707,270 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Tersera
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | 7,220,247 | ⤷ Try a Trial |
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | 4,767,628 | ⤷ Try a Trial |
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-001 | Dec 28, 2004 | 5,795,864 | ⤷ Try a Trial |
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 019726-001 | Dec 29, 1989 | 5,366,734 | ⤷ Try a Trial |
| Tersera | ZOLADEX | goserelin acetate | IMPLANT;IMPLANTATION | 020578-001 | Jan 11, 1996 | 4,767,628 | ⤷ Try a Trial |
| Tersera | VARUBI | rolapitant hydrochloride | EMULSION;INTRAVENOUS | 208399-001 | Oct 25, 2017 | 8,796,299 | ⤷ Try a Trial |
| Tersera | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-003 | Dec 28, 2004 | 5,795,864 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Tersera Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2017145628 | ⤷ Try a Trial |
| Russian Federation | 2326120 | ⤷ Try a Trial |
| Poland | 2203444 | ⤷ Try a Trial |
| Denmark | 2091940 | ⤷ Try a Trial |
| Singapore | 178403 | ⤷ Try a Trial |
| Argentina | 060303 | ⤷ Try a Trial |
| Germany | 60225067 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tersera Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1463716 | LUC00043 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING ROLAPITANT HYDROCHLORIDE MONOHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1180/001 20170424 |
| 1463716 | C20170033 00237 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT;REG NO/DATE: EU/1/17/1180 24.04.2017 |
| 1463716 | 1790044-0 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING ROLAPITANT HYDROCHLORIDE MONOHYDRATE; REG. NO/DATE: EU/1/17/1180/001 20170424 |
| 2004646 | PA2017031 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANTO HIDROCHLORIDO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/17/1180/001 20170420 |
| 2091940 | C201830016 | Spain | ⤷ Try a Trial | PRODUCT NAME: TELOTRISTAT, O ESTER FARMACEUTICAMENTE ACEPTABLE, O UNA SALA DEL MISMO, EN PARTICULAR TELOTRISTAT DE ESTILO, MAS PARTICULARMENTE LA SAL HIPURATO DE TELOTRISTAT DE ETILO; NATIONAL AUTHORISATION NUMBER: EU/1/17/1224; DATE OF AUTHORISATION: 20170918; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1224; DATE OF FIRST AUTHORISATION IN EEA: 20170918 |
| 1463716 | 122017000080 | Germany | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, EINSCHLIESSLICH ROLAPITANT HYDROCHLORID-MONOHYDRAT; REGISTRATION NO/DATE: EU/1/17/1180 20170420 |
| 1463716 | C 2017 036 | Romania | ⤷ Try a Trial | PRODUCT NAME: ROLAPITANT, OPTIONAL SUB FORMA UNEI SARI ACCEPTABILE FARMACEUTIC, INCLUSIV CLORHIDRAT DE ROLAPITANT MONOHIDRAT; NATIONAL AUTHORISATION NUMBER: EU/1/17/1180/001; DATE OF NATIONAL AUTHORISATION: 20170420; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1180/001; DATE OF FIRST AUTHORISATION IN EEA: 20170420 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
